Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011 Oct; 141(4):1194-201.